
|Articles|June 1, 2001
Surface-treated prostheses receive FDA approval
Minneapolis-American Medical Systems has received FDA approval for InhibiZone, an antibiotic surface treatment used on its AMS 700 series penile prostheses. The treatment is impregnated through a patented process into the tissue-contacting surfaces of the prostheses. In laboratory testing, the device elutes the drugs from the surface when exposed to a warm, moist environment, providing antibiotic action both on the surface and in a zone surrounding the treated device, according to the company.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5







